Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease

NCT00305201 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Withdrawn due to lack of study participants

Conditions

Kawasaki Disease

Interventions

DRUG: pravastatin

Sponsor

Pontificia Universidad Catolica de Chile

Collaborators

[object Object]